Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Secondary prevention in acute myocardial infarction.

Authors: S Yusuf; C J Pepine; C Garces; H Pouleur; D Salem; J Kostis; C Benedict; M Rousseau; M Bourassa; B Pitt
Journal: Lancet Date: 1992-11-14 Impact factor: 79.321

7. Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group.

Authors:
Journal: Eur Heart J Date: 1988-04 Impact factor: 29.983

8. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.

Authors:
Journal: JAMA Date: 1982-03-26 Impact factor: 56.272

9. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.

Authors:
Journal: Lancet Date: 1986-07-12 Impact factor: 79.321

10. [Nifedipine in secondary prevention after myocardial infarction. SPRINT Study Group].

Authors:
Journal: Harefuah Date: 1989-01-01

11 in total

1. Effect of drug combinations on admission for recurrent myocardial infarction.

Authors: Menno E van der Elst; Marcel L Bouvy; Cornelis J de Blaey; Anthonius de Boer
Journal: Heart Date: 2007-05-13 Impact factor: 5.994

2. Trial is needed of ACE inhibitors plus beta blockers in survivors of myocardial infarction.

Authors: F A McAlister
Journal: BMJ Date: 1998-09-12

3. Secondary prevention in acute myocardial infarction. Data cited from two studies were inaccurate.

Authors: N A Herity
Journal: BMJ Date: 1998-10-24

4. Secondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issues.

Authors: P Underwood; P Beck
Journal: Qual Saf Health Care Date: 2002-09

5. Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial.

Authors: G Feder; C Griffiths; S Eldridge; M Spence
Journal: BMJ Date: 1999-06-05

Review 6. Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 3: Angiotensin-converting-enzyme inhibitors.

Authors: J M Wright
Journal: CMAJ Date: 2000-08-08 Impact factor: 8.262

Review 7. Current concepts in secondary prevention after acute myocardial infarction.

Authors: R H Mehta; E Bossone; K A Eagle
Journal: Herz Date: 2000-02 Impact factor: 1.443

8. Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study.

Authors: R J McManus; J Mant; C F M Meulendijks; R A Salter; H M Pattison; A K Roalfe; F D R Hobbs
Journal: BMJ Date: 2002-02-23

9. Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus.

Authors: Casper H Jørgensen; Gunnar H Gislason; Ole Ahlehoff; Charlotte Andersson; Christian Torp-Pedersen; Peter R Hansen
Journal: BMC Cardiovasc Disord Date: 2014-01-09 Impact factor: 2.298

10. Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England.

Authors: Paul R Ward; Peter R Noyce; Antony S St Leger
Journal: Ther Clin Risk Manag Date: 2005-03 Impact factor: 2.423